Contraceptive discontinuation attributed to method dissatisfaction in the United States

Contraception
Caroline MoreauJames Trussell

Abstract

This study examines contraceptive discontinuation due to method dissatisfaction among women in the United States. The study population, drawn from the 2002 National Survey of Family Growth, consisted of 6724 women (15-44 years of age) who had ever used a reversible contraceptive method. We first estimated the overall proportion of women who had ever discontinued their contraceptive due to dissatisfaction. We then calculated method-specific discontinuation risks due to dissatisfaction and analyzed the reasons for dissatisfaction given by women who had ever stopped using Norplant, Depo-Provera, oral contraceptives or condoms. Overall, 46% of women had ever discontinued at least one method because they were unsatisfied with it. Dissatisfaction-related discontinuation risks varied widely by method: the diaphragm and cervical cap showed the highest proportions of such discontinuation (52%), followed by long-acting hormonal methods (42%). Oral contraceptives were associated with an intermediate risk of dissatisfaction-related discontinuation (29%), while condoms had the lowest risk (12%). A broader understanding of women's concerns and experiences using contraception could help health care providers redesign counseling strategies to ...Continue Reading

References

Sep 1, 1996·Obstetrics and Gynecology·L J Beckman, S M Harvey
Jun 1, 2002·Obstetrics and Gynecology·Tiina BackmanMarkku Koskenvuo
Aug 4, 2004·Contraception·James Trussell
May 2, 2006·American Journal of Obstetrics and Gynecology·Larissa R Brunner HuberSusan Schayes
Jul 18, 2006·Human Reproduction·Nathalie BajosJosiane Warszawski
Aug 1, 2006·Health Care for Women International·Annie Mills, Lesley Barclay

❮ Previous
Next ❯

Citations

Apr 30, 2010·Maternal and Child Health Journal·Jennifer L ErsekJan Warren-Findlow
Jan 14, 2011·Health Care for Women International·Haifa Abdulaziz Al-Turki
Jul 16, 2008·Current Opinion in Pediatrics·Sarah A B Pitts, S J Emans
Sep 18, 2008·International Journal of Clinical Practice·G M SoaresR A Ferriani
Sep 6, 2011·International Journal of Women's Health·Jessica W Kiley, Lee P Shulman
Apr 10, 2010·Journal of Women's Health·Larissa R Brunner Huber, Jennifer L Ersek
Nov 3, 2010·Journal of Women's Health·Kelli Stidham HallCarolyn Westhoff
Oct 28, 2011·Journal of Women's Health·Iñaki LetePaloma Lobo
Oct 26, 2013·Journal of Women's Health·Elizabeth R MayedaCarolyn L Westhoff
Sep 3, 2013·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Rossella E Nappi, UNKNOWN Italian Nuvaring Study Group
Apr 3, 2009·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Dirk WildemeerschAmaury Andrade
May 9, 2013·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Edward T DassahGerald Owusu-Asubonteng
Oct 16, 2014·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Rossella E NappiChiara Benedetto
Sep 3, 2010·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Iñaki Lete Lasa
Jul 1, 2009·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Sergio Haimovich
Nov 19, 2013·Journal of Pediatric and Adolescent Gynecology·David L HowardJulie L Strickland
Jul 31, 2012·Contraception·Suzanne BurloneMaria I Rodriguez
Feb 14, 2012·Sexual & Reproductive Healthcare : Official Journal of the Swedish Association of Midwives·Annelie Sköld, Margareta Larsson
Aug 2, 2011·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·Diana G FosterClaire D Brindis
Sep 17, 2011·Contraception·Ana Laura Carneiro Gomes FerreiraCynthia Braga
Aug 24, 2010·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Iñaki LeteRoberto Arina
Dec 8, 2010·Contraception·David A Grimes, Kenneth F Schulz
Dec 7, 2010·Patient Education and Counseling·Laura SubramanianJohn M Pile
Nov 17, 2009·Contraception·David A Grimes
Apr 12, 2008·Contraception·Sujatha Prabhakaran
Aug 8, 2009·International Journal of Dermatology·C Stanley ChanTed Rosen
Sep 23, 2008·Perspectives on Sexual and Reproductive Health·Debra KalmussGretchen Stuart
Apr 27, 2010·Perspectives on Sexual and Reproductive Health·Linda Hock-LongRoberta Herceg-Baron
Aug 1, 2015·Journal of Midwifery & Women's Health·Richard J Fehring, Mary Schneider
Jul 22, 2014·Perspectives on Sexual and Reproductive Health·Anu Manchikanti Gomez, Jennifer B Clark
Mar 27, 2016·Pharmacology & Therapeutics·Jing H Chao, Stephanie T Page
Aug 20, 2015·Perspectives on Sexual and Reproductive Health·Rachel K JonesJennifer Frost
Nov 26, 2015·Obstetrics and Gynecology Clinics of North America·EmmaKate Friedlander, Bliss Kaneshiro

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.